Atrial flutter echocardiography: Difference between revisions
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
==Echocardiography== | ==Echocardiography== | ||
TTE is the preferred modality for evaluating the sizes of right and left atria in atrial flutter. It can also be used to assist in the diagnosis of valvular heart disease, left ventricular hypertrophy, heart failure and pericardial disease. | TTE is the preferred modality for evaluating the sizes of right and left atria in atrial flutter. It can also be used to assist in the diagnosis of [[valvular heart disease]], [[left ventricular hypertrophy]], [[heart failure]] and pericardial disease. | ||
==References== | ==References== | ||
Revision as of 01:26, 22 January 2013
|
Atrial flutter Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Atrial flutter echocardiography On the Web |
|
American Roentgen Ray Society Images of Atrial flutter echocardiography |
|
Risk calculators and risk factors for Atrial flutter echocardiography |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Transthoracic echocardiography (TTE) is used in atrial flutter to evaluate the sizes of left and right atria. Transesophageal echocardiography (TEE) is used to evaluate the presence of thrombus and selection of candidates for cardioversion.
Echocardiography
TTE is the preferred modality for evaluating the sizes of right and left atria in atrial flutter. It can also be used to assist in the diagnosis of valvular heart disease, left ventricular hypertrophy, heart failure and pericardial disease.